Log in

NASDAQ:DBVT - DBV TECHNOLOGIE/S Stock Price, Forecast & News

$9.67
-0.01 (-0.10 %)
(As of 02/20/2020 03:59 AM ET)
Today's Range
$9.55
Now: $9.67
$9.83
50-Day Range
$9.30
MA: $10.95
$12.98
52-Week Range
$6.63
Now: $9.67
$13.49
Volume453,000 shs
Average Volume514,424 shs
Market Capitalization$882.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.9
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase II clinical trial for the treatment of Immunoglobulin E mediated cow's milk protein allergy (CMPA) and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordatella pertussis. Read More…

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DBVT
CUSIPN/A
Phone33-1-55-42-78-78

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.17 million
Book Value$2.41 per share

Profitability

Miscellaneous

Employees244
Market Cap$882.70 million
Next Earnings Date4/6/2020 (Estimated)
OptionableOptionable

Receive DBVT News and Ratings via Email

Sign-up to receive the latest news and ratings for DBVT and its competitors with MarketBeat's FREE daily newsletter.


DBV TECHNOLOGIE/S (NASDAQ:DBVT) Frequently Asked Questions

What is DBV TECHNOLOGIE/S's stock symbol?

DBV TECHNOLOGIE/S trades on the NASDAQ under the ticker symbol "DBVT."

How were DBV TECHNOLOGIE/S's earnings last quarter?

DBV TECHNOLOGIE/S (NASDAQ:DBVT) announced its quarterly earnings results on Thursday, March, 26th. The company reported ($0.79) earnings per share for the quarter, missing analysts' consensus estimates of ($0.44) by $0.35. View DBV TECHNOLOGIE/S's Earnings History.

When is DBV TECHNOLOGIE/S's next earnings date?

DBV TECHNOLOGIE/S is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for DBV TECHNOLOGIE/S.

What price target have analysts set for DBVT?

6 Wall Street analysts have issued 12 month target prices for DBV TECHNOLOGIE/S's stock. Their forecasts range from $14.00 to $25.00. On average, they anticipate DBV TECHNOLOGIE/S's share price to reach $18.20 in the next year. This suggests a possible upside of 88.2% from the stock's current price. View Analyst Price Targets for DBV TECHNOLOGIE/S.

What is the consensus analysts' recommendation for DBV TECHNOLOGIE/S?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DBV TECHNOLOGIE/S in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for DBV TECHNOLOGIE/S.

Has DBV TECHNOLOGIE/S been receiving favorable news coverage?

Press coverage about DBVT stock has trended negative this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. DBV TECHNOLOGIE/S earned a news sentiment score of -2.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 9.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for DBV TECHNOLOGIE/S.

Who are some of DBV TECHNOLOGIE/S's key competitors?

What other stocks do shareholders of DBV TECHNOLOGIE/S own?

Who are DBV TECHNOLOGIE/S's key executives?

DBV TECHNOLOGIE/S's management team includes the folowing people:
  • Dr. Pierre-Henri Benhamou, Co-Founder & Non-Exec. Chairman (Age 64)
  • Mr. David Schilansky, Deputy CEO & CFO (Age 44)
  • Dr. Laurent Martin, Chief Devel. Officer (Age 52)
  • Mr. Daniel Tassé, CEO & Director (Age 59)
  • Mr. Bertrand Dupont, Co-Founder & CTO (Age 67)

Who are DBV TECHNOLOGIE/S's major shareholders?

DBV TECHNOLOGIE/S's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Boxer Capital LLC (6.99%), ArrowMark Colorado Holdings LLC (4.92%), Perceptive Advisors LLC (4.78%), First Midwest Bank Trust Division (0.64%), Syquant Capital Sas (0.47%) and Artisan Partners Limited Partnership (0.41%).

Which institutional investors are selling DBV TECHNOLOGIE/S stock?

DBVT stock was sold by a variety of institutional investors in the last quarter, including First Midwest Bank Trust Division, UBS Group AG and Goldman Sachs Group Inc..

Which institutional investors are buying DBV TECHNOLOGIE/S stock?

DBVT stock was acquired by a variety of institutional investors in the last quarter, including Boxer Capital LLC, Perceptive Advisors LLC, ArrowMark Colorado Holdings LLC, Syquant Capital Sas, Marshall Wace LLP, Bailard Inc., Ikarian Capital LLC and Premier Asset Management LLC.

How do I buy shares of DBV TECHNOLOGIE/S?

Shares of DBVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is DBV TECHNOLOGIE/S's stock price today?

One share of DBVT stock can currently be purchased for approximately $9.67.

How big of a company is DBV TECHNOLOGIE/S?

DBV TECHNOLOGIE/S has a market capitalization of $882.70 million and generates $17.17 million in revenue each year. The company earns $-196,140,000.00 in net income (profit) each year or ($3.39) on an earnings per share basis. DBV TECHNOLOGIE/S employs 244 workers across the globe.View Additional Information About DBV TECHNOLOGIE/S.

What is DBV TECHNOLOGIE/S's official website?

The official website for DBV TECHNOLOGIE/S is http://www.dbv-technologies.com/.

How can I contact DBV TECHNOLOGIE/S?

DBV TECHNOLOGIE/S's mailing address is 177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE I0, 92120. The company can be reached via phone at 33-1-55-42-78-78 or via email at [email protected]


MarketBeat Community Rating for DBV TECHNOLOGIE/S (NASDAQ DBVT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  350 (Vote Outperform)
Underperform Votes:  372 (Vote Underperform)
Total Votes:  722
MarketBeat's community ratings are surveys of what our community members think about DBV TECHNOLOGIE/S and other stocks. Vote "Outperform" if you believe DBVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DBVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel